Evidence map›Paper›PMID 30699160›Full record

ArticlePloS one2019

Targeted HIV testing for male partners of HIV-positive pregnant women in a high prevalence setting in Nigeria.

Semiu Olatunde Gbadamosi, Ijeoma Uchenna Itanyi, William Nii Ayitey Menson, John Olajide Olawepo, Tamara Bruno, Amaka Grace Ogidi, Dina V Patel, John Okpanachi Oko, Chima Ariel Onoka, Echezona Edozie Ezeanolue

Abstract readComparative Study
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Semiu Olatunde GbadamosiFlorida International University Robert Stempel College of Public Health & Social Work, Miami, FL, United States of America.ORCID 0000-0003-2048-2943
Ijeoma Uchenna ItanyiDepartment of Community Medicine, College of Medicine, University of Nigeria, Nsukka, Enugu, Nigeria.
William Nii Ayitey MensonIndependent Researcher, Las Vegas, NV, United States of America.
John Olajide OlawepoSchool of Community Health Sciences, University of Nevada-Las Vegas, Las Vegas, NV, United States of America.ORCID 0000-0001-6732-1042
Tamara BrunoIndependent Researcher, Las Vegas, NV, United States of America.
Amaka Grace OgidiResearch Resource Center, College of Medicine, University of Nigeria, Nsukka, Enugu, Nigeria.ORCID 0000-0002-8282-1173
Dina V PatelHealthySunrise Foundation, Las Vegas, NV, United States of America.
John Okpanachi OkoCaritas Nigeria, Abuja, Federal Capital Territory, Nigeria.
Chima Ariel OnokaDepartment of Community Medicine, College of Medicine, University of Nigeria, Nsukka, Enugu, Nigeria.ORCID 0000-0002-3328-1887
Echezona Edozie EzeanolueHealthySunrise Foundation, Las Vegas, NV, United States of America.

Funding

Intervention for Sustained Testing and Retention (iSTAR) Among HIV-infected PatientsR01HD087994 · NICHD · UNIVERSITY OF NEVADA LAS VEGAS · PI EZEANOLUE, ECHEZONA EDOZIE, ONOKA, CHIMA · 2016 to 2017
$1.9M
Point-of-Delivery Prenatal Test Results through mHealth to Improve Birth OutcomeR21TW010252 · FIC · UNIVERSITY OF NEVADA LAS VEGAS · PI EZEANOLUE, ECHEZONA EDOZIE · 2015 to 2016
$322k
FIC NIH HHS R21 TW010252NICHD NIH HHS R01 HD087994
6 · The paper itself

Abstract

backgroundPartner HIV testing during pregnancy has remained abysmally low in sub-Saharan Africa, particularly in Nigeria. Males rarely attend antenatal clinics with their female partners, limiting the few opportunities available to offer them HIV testing. In this study, we evaluated the scale-up of the Healthy Beginning Initiative (HBI), a community-driven evidenced-based intervention to increase HIV testing among pregnant women and their male partners. Our objectives were to determine the: (1) male partner participation rate; (2) prevalence of HIV among male partners of pregnant women; (3) factors associated with HIV positivity among male partners of HIV-positive pregnant women.

methodsWe reviewed program data of expectant parents enrolled in HBI in Benue State, north-central Nigeria. During HBI, trained lay health workers provided educational and counseling sessions, and offered free onsite integrated testing for HIV, hepatitis B virus and sickle cell genotype to pregnant women and their male partners who participated in incentivized, church-organized baby showers. Each participant completed an interviewer-administered questionnaire on demographics, lifestyle habits, and HIV testing history. Chi-square test was used to compare the characteristics of HIV-positive and HIV-negative male partners. Simple and multivariable logistic regression models were used to determine the association between participants' characteristics and HIV positivity among male partners of HIV-positive women.

resultsMale partner participation rate was 57% (5264/9231). Overall HIV prevalence was 6.1% (891/14495) with significantly higher rates in women (7.4%, 681/9231) compared to men (4.0%, 210/5264). Among the 681 HIV-positive women, 289 male partners received HIV testing; 37.7% (109/289) were found to be HIV-positive. In multivariate analysis, older age (adjusted odds ratio [aOR]: 2.45, 95% confidence interval [CI]: 1.27-4.72 for age 30-39 years vs. <30 years; aOR: 2.39, CI: 1.18-4.82 for age ≥40 years vs. <30 years) and self-reported daily alcohol intake (vs. never (aOR: 0.35, CI: 0.13-0.96)) were associated with HIV positivity in male partners of HIV-positive women.

conclusionThe community-based congregational approach is a potential strategy to increase male partner HIV testing towards achieving the UNAIDS goal of 90% HIV screening. Targeting male partners of HIV-positive women for screening may provide a higher yield of HIV diagnosis and the opportunity to engage known positives in care in this population.

Indexed as

HIV-1HIV SeronegativityAdultAge FactorsFemaleHumansMaleNigeriaPregnancyPregnancy Complications, InfectiousPrevalenceSex FactorsSurveys and Questionnaires

Identifiers

PMID30699160
PMCPMC6353157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.